---
title: "FDA Approves Shanghai Henlius Biotech's Investigational New Drug Application for Anti-Neurodegenerative Disease Drug"
date: "2025-02-10 21:16:29"
summary: "Shanghai Henlius Biotech said the United States Food and Drug Administration approved its investigational new drug application of innovative small molecular HLX99, a Monday bourse filing said. The drug is a small molecule coupled chemical drug and is purposed for the treatment of amyotrophic lateral sclerosis, a neurodegenerative disease that..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Shanghai Henlius Biotech said the United States Food and Drug Administration approved its investigational new drug application of innovative small molecular HLX99, a Monday bourse filing said.

The drug is a small molecule coupled chemical drug and is purposed for the treatment of amyotrophic lateral sclerosis, a neurodegenerative disease that causes loss of muscle innervation.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465817:0/)
